UPDATE 1-FDA approves first generic version of Teva MS drug Copaxone

April 16 (Reuters) - The U.S. Food and Drug Administration approved on Thursday the first generic version of Teva Pharmaceuticals Industries Ltd's top-selling multiple sclerosis drug, Copaxone.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.